MetLife, Inc.
MET
$76.56
$0.230.30%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.33% | -1.08% | 7.21% | 3.05% | -1.50% |
| Total Other Revenue | -97.17% | -521.43% | 372.27% | -143.55% | 215.54% |
| Total Revenue | -5.85% | -2.71% | 15.64% | -1.90% | 16.22% |
| Cost of Revenue | 2.00% | -2.24% | 8.62% | 2.45% | -2.10% |
| Gross Profit | -23.02% | -4.24% | 40.22% | -15.24% | 96.70% |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 7.72% | 4.34% | 4.71% | 1.71% | 2.24% |
| Total Operating Expenses | 3.10% | -1.08% | 7.87% | 2.32% | -1.30% |
| Operating Income | -56.24% | -23.94% | 210.73% | -46.79% | 138,950.00% |
| Income Before Tax | -39.32% | -18.47% | 29.57% | 46.76% | 273.41% |
| Income Tax Expenses | -52.83% | -1.61% | 137.65% | -67.58% | 1,574.36% |
| Earnings from Continuing Operations | -32.74% | -22.88% | 8.57% | 107.65% | 170.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -700.00% | 14.29% | 37.50% | 42.86% | 116.67% |
| Net Income | -33.23% | -22.94% | 9.00% | 109.39% | 174.44% |
| EBIT | -56.24% | -23.94% | 210.73% | -46.79% | 138,950.00% |
| EBITDA | -55.67% | -23.54% | 201.24% | -34.21% | 9,946.43% |
| EPS Basic | -32.51% | -18.94% | 16.46% | 130.07% | 224.66% |
| Normalized Basic EPS | -36.72% | -13.69% | 38.23% | 57.56% | 308.90% |
| EPS Diluted | -32.60% | -18.33% | 16.36% | 130.72% | 223.21% |
| Normalized Diluted EPS | -36.74% | -13.71% | 38.25% | 57.48% | 308.58% |
| Average Basic Shares Outstanding | -4.95% | -5.59% | -5.66% | -6.17% | -6.93% |
| Average Diluted Shares Outstanding | -4.92% | -5.55% | -5.68% | -6.12% | -6.86% |
| Dividend Per Share | 4.13% | 4.13% | 4.81% | 4.81% | 4.81% |
| Payout Ratio | 0.48% | 0.27% | -0.09% | -0.53% | -0.64% |